| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/14/2010 | CA2728374A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/13/2010 | EP2144065A1 HLA-E Binding |
| 01/13/2010 | EP2143795A2 Anti-CD20 monoclonal antibody |
| 01/13/2010 | EP2143784A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2143731A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 01/13/2010 | EP2143730A2 Modified peptides and their use for the treatment of autoimmune diseases |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142660A2 Methods and systems for o-glycosylating proteins |
| 01/13/2010 | EP2142568A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/13/2010 | EP2027108B1 Histamine receptor antagonists comprising an azepin core |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1487453B1 N- ¬(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl methyl -2- 3-¬(methylsulphonyl)amino phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 01/13/2010 | EP1427462B1 Method for inducing selectively suppressed immune response |
| 01/13/2010 | EP1221968B1 Method of obtaining cellular immune responses from proteins |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579582C Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the preparation of medicament for treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of aller |
| 01/13/2010 | CN100579577C Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/13/2010 | CN100579561C Oral Chinese medicine composition for treating urtica |
| 01/13/2010 | CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder |
| 01/13/2010 | CN100579535C Improvements in or relating to immune functions |
| 01/13/2010 | CN100579534C Application of S-adenyhomotype cysteine in medical preparation |
| 01/13/2010 | CN100579527C Compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and use method thereof |
| 01/13/2010 | CN100579521C Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/13/2010 | CN100579393C Poria-cocos eight-treasures noodles and preparing method |
| 01/12/2010 | US7645903 immunoglobulins; affinity chromatography |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645743 Administering immunity linkers with more than one binding site, wherein second site binds to target and individual has pre-existing cellular or humoral immune response to first site; high speed response to public health needs such as pandemic infections; biological warfare; vaccines |
| 01/12/2010 | US7645449 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2331846C Expression vectors for stimulating an immune response and methods of using the same |
| 01/12/2010 | CA2309604C Compositions and methods for targeted delivery of factors |
| 01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010003127A2 Antagonists of prostaglandin d2 receptors |
| 01/07/2010 | WO2010003120A2 Antagonists of prostaglandin d2 receptors |
| 01/07/2010 | WO2010003092A1 Methods and compositions for reducing inflammation and treating inflammatory disorders |
| 01/07/2010 | WO2010003009A2 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | WO2010003002A2 Modulation of follicular helper t cells |
| 01/07/2010 | WO2010002895A2 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001509A1 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 01/07/2010 | WO2010001257A2 Novel solid state forms of laquinimod and its sodium salt |
| 01/07/2010 | WO2010000873A1 Modification of allergens for immunotherapy |
| 01/07/2010 | WO2010000730A1 Immunosuppressive blood cells and methods of producing same |
| 01/07/2010 | WO2010000633A1 Novel phenylpyrazinones as kinase inhibitors |
| 01/07/2010 | WO2010000437A1 Antiallergic marine biopolymers |
| 01/07/2010 | WO2010000127A1 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale |
| 01/07/2010 | WO2009140626A3 Long term disease modification using immunostimulatory oligonucleotides |
| 01/07/2010 | WO2009140128A3 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 01/07/2010 | WO2009131730A3 IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS |
| 01/07/2010 | WO2009115517A3 Pyridines and pyrazines as inhibitors of pi3k |
| 01/07/2010 | WO2009114860A3 Activated mesenchymal stem cells for the prevention and repair of inflammatory states |
| 01/07/2010 | WO2009112502A9 Agent for treating disease |
| 01/07/2010 | US20100004342 LFA-1 Inhibitors and Use Thereof |
| 01/07/2010 | US20100004334 Nutritional Compositions Containing Punicalagins |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004285 POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID |
| 01/07/2010 | US20100004270 Inhibitors of bruton's tyrosine kinase |
| 01/07/2010 | US20100004265 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof |
| 01/07/2010 | US20100004210 Method and substances for treating t-cell mediated autoimmune diseases |
| 01/07/2010 | US20100004174 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100003286 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003275 Immunostimulatory Composition comprising Lipoprotein in Microalgae Extract |
| 01/07/2010 | US20100003272 Method for Expanding Monocytes |
| 01/07/2010 | US20100003266 Targeted immune conjugates |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003252 Blocking immune response to a graft |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003228 T-cell vaccine |
| 01/07/2010 | US20100003219 Methods to Increase Transgene Expression From Bacterial-Based Delivery Systems by Co-Expressing Suppressors of the Eukaryotic Type I Interferon Response |
| 01/07/2010 | DE202009013065U1 Granatapfelpolyphenole, Vitamin D und Spurenelemente enthaltende Zusammensetzung Pomegranate polyphenols, vitamin D and trace elements containing composition |
| 01/07/2010 | CA2729818A1 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
| 01/07/2010 | CA2729775A1 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | CA2729286A1 Nutritional compositions containing punicalagins |
| 01/07/2010 | CA2729151A1 Modification of allergens for immunotherapy |
| 01/07/2010 | CA2729080A1 Cattle vaccines |
| 01/07/2010 | CA2728683A1 Novel phenylpyrazinones as kinase inhibitors |
| 01/07/2010 | CA2726221A1 Antiallergic marine biopolymers |